Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
editorial
. 1983 Nov 15;129(10):1085–1087.

Bendectin: the wrong way to regulate drug availability.

J S Leeder, S P Spielberg, S M MacLeod
PMCID: PMC1875483  PMID: 6627167

Full text

PDF
1085

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUNDE C. A., BOWLES D. M. A technique for controlled survey of case records. Curr Ther Res Clin Exp. 1963 May;5:245–248. [PubMed] [Google Scholar]
  2. Brent R. R. The Bendectin Saga: another American tragedy (Brent, '80). Teratology. 1983 Apr;27(2):283–286. doi: 10.1002/tera.1420270217. [DOI] [PubMed] [Google Scholar]
  3. Cordero J. F., Oakley G. P., Greenberg F., James L. M. Is Bendectin a teratogen? JAMA. 1981 Jun 12;245(22):2307–2310. [PubMed] [Google Scholar]
  4. DonnaiD, Harris R. Unusual fetal malformations after antiemetics in early pregnancy. Br Med J. 1978 Mar 18;1(6114):691–692. doi: 10.1136/bmj.1.6114.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fleming D. M., Knox J. D., Crombie D. L. Debendox in early pregnancy and fetal malformation. Br Med J (Clin Res Ed) 1981 Jul 11;283(6284):99–101. doi: 10.1136/bmj.283.6284.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Harron D. W., Griffiths K., Shanks R. G. Debendox and congenital malformations in Northern Ireland. Br Med J. 1980 Nov 22;281(6252):1379–1381. doi: 10.1136/bmj.281.6252.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holmes L. B. Teratogen update: bendectin. Teratology. 1983 Apr;27(2):277–281. doi: 10.1002/tera.1420270216. [DOI] [PubMed] [Google Scholar]
  8. Jick H., Holmes L. B., Hunter J. R., Madsen S., Stergachis A. First-trimester drug use and congenital disorders. JAMA. 1981 Jul 24;246(4):343–346. [PubMed] [Google Scholar]
  9. Kolata G. B. How safe is Bendectin? Science. 1980 Oct 31;210(4469):518–519. doi: 10.1126/science.7423201. [DOI] [PubMed] [Google Scholar]
  10. Michaelis J., Michaelis H., Glück E., Koller S. Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations. Teratology. 1983 Feb;27(1):57–64. doi: 10.1002/tera.1420270109. [DOI] [PubMed] [Google Scholar]
  11. Milkovich L., van den Berg B. J. An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol. 1976 May 15;125(2):244–248. doi: 10.1016/0002-9378(76)90601-3. [DOI] [PubMed] [Google Scholar]
  12. Mitchell A. A., Rosenberg L., Shapiro S., Slone D. Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA. 1981 Jun 12;245(22):2311–2314. [PubMed] [Google Scholar]
  13. Morelock S., Hingson R., Kayne H., Dooling E., Zuckerman B., Day N., Alpert J. J., Flowerdew G. Bendectin and fetal development. A study of Boston City Hospital. Am J Obstet Gynecol. 1982 Jan 15;142(2):209–213. doi: 10.1016/s0002-9378(16)32338-9. [DOI] [PubMed] [Google Scholar]
  14. Paterson D. C. Congenital deformities. Can Med Assoc J. 1969 Aug 9;101(3):175–176. [PMC free article] [PubMed] [Google Scholar]
  15. Rothman K. J., Fyler D. C., Goldblatt A., Kreidberg M. B. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol. 1979 Apr;109(4):433–439. doi: 10.1093/oxfordjournals.aje.a112701. [DOI] [PubMed] [Google Scholar]
  16. Shapiro S., Heinonen O. P., Siskind V., Kaufman D. W., Monson R. R., Slone D. Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol. 1977 Jul 1;128(5):480–485. doi: 10.1016/0002-9378(77)90028-x. [DOI] [PubMed] [Google Scholar]
  17. Smithells R. W., Sheppard S. Teratogenicity testing in humans: a method demonstrating safety of bendectin. Teratology. 1978 Feb;17(1):31–35. doi: 10.1002/tera.1420170109. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES